Loss of tight junction proteins (Claudin 1, 4,and 7) correlates with aggressive behavior in colorectal carcinoma

Medical Science Monitor

Volumn 20, Issue , 2014, Pages 1255-1262

  Süren, Dinç ^a   Yildirim, Mustafa ^b   Kaya, Vildan ^c   Alikanoǧlu, Arsenal Sezgin ^a   Bülbüller, Nurullah ^a   Yildiz, Mustafa ^a   Sezer, Cem ^a  

^a Department of Pathology Antalya Education and Research Hospital ^*  (Turkey)

^b Ministry of Health Batman Regional Government Hospital   (Turkey)

^c SULEYMAN DEMIREL UNIVERSITY   (Turkey)

Author keywords

Claudin 1; Claudin 4; Claudin 7; Colorectal neoplasms; Prognosis; Tight junctions

Indexed keywords

CLAUDIN 1; CLAUDIN 4; CLAUDIN 7; TIGHT JUNCTION PROTEIN; CLAUDIN; CLDN1 PROTEIN, HUMAN; CLDN4 PROTEIN, HUMAN; CLDN7 PROTEIN, HUMAN;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER STAGING; COLLOID CARCINOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN DEPLETION; PROTEIN EXPRESSION; SIGNET RING CARCINOMA; TUMOR INVASION; CELL MEMBRANE PERMEABILITY; CELL MOTION; CELL PROLIFERATION; COLORECTAL TUMOR; DEFICIENCY; METABOLISM; METASTASIS; PATHOPHYSIOLOGY; PHYSIOLOGY;

CELL MEMBRANE PERMEABILITY; CELL MOVEMENT; CELL PROLIFERATION; CLAUDIN-1; CLAUDIN-4; CLAUDINS; COLORECTAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; TIGHT JUNCTION PROTEINS;

EID: 84905000263     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.890598     Document Type: Article

References (39)

1. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. CA Cancer J Clin, 2013; 63: 11-30
2. Edge SB, Byrd DR, Compton CC et al: Editors. AJCC (American Joint Committee on Cancer) Cancer Staging Manual, 7th edition. New York: Springer, 2010
3. Tsukita S, Furuse M, Itoh M: Multifunctional strands in tight junctions. Nature Reviews Molecular Cell Biology, 2001; 2: 285-93
4. Rahner C, Mitic L, Anderson JM: Heterogenity in expression and subcellular localization of Claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology, 2001; 120: 411-22
5. Krause G, Winkler L, Mueller SL et al: Structure and function of Claudins. Biochim Biophys Acta, 2008; 1778: 631-45
6. Ouban A, Ahmed AA: Claudins in human cancer: a review. Histol Histopathol, 2010; 25: 83-90
7. Will C, Fromm M, Muller D: Claudin tight junction proteins: novel aspects in paracellular transport. Perit Dial Int, 2008; 28: 577-84
8. Oliveira SS, Morgado-Diaz JA: Claudins: multifunctional players in epithelial tight junctions and their role in cancer. Cell Mol Life Sci, 2007; 64: 17-28
9. Bornholdt J, Friis S, Godiksen S et al: The level of Claudin-7 is reduced as an early event in colorectal carcinogenesis. BMC Cancer, 2011; 11: 65
10. Han DP, Zhu QL, Cui JT et al: Polo-like kinase 1 is overexpressed in colorectal cancer and participates in the migration and invasion of colorectal cancer cells. Med Sci Monit, 2012; 18(6): BR237-46
11. Gao L, Bai L, Nan QZ: Activation of Rho GTPase Cdc42 promotes adhesion and invasion in colorectal cancer cells. Med Sci Monit, 2013; 19: 201-7
12. Fritzsche FR, Oelrich B, Johannsen M et al: Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas. Clin Cancer Res, 2008; 14: 7035-42
13. Singh AB, Sharma A, Dhawan P: Claudin family of proteins and cancer: an overview. J Oncol, 2010; 2010: 541957
14. Matsuoka T, Mitomi H, Fukui N et al: Cluster analysis of Claudin-1 and -4, E-cadherin, and b-catenin expression in colorectal cancers. J Surg Oncol, 2011; 103: 674-86
15. Martin TA, Jiang WG: Loss of tight junction barrier function and its role in cancer metastasis. Biochimica et Biophysica Acta, 2009; 4: 872-91
16. Miyoshi J, Takai Y: Molecular perspective on tight junction assembly and epithelial polarity. Advanced Drug Delivery Reviews, 2005; 57: 815-25
17. Tan C, Cruet-Hennequart S, Troussard A et al: Regulation of tumor angiogenesis by integrin-linked kinase (ILK). Cancer Cell, 2004; 5: 79-90
18. Kominsky SL, Argani P, Korz D et al: Loss of the tight junction protein Claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene, 2003; 22: 2021-33
19. Usami Y, Chiba H, Nakayama F et al: Reduced expression of Claudin-7 correlates with invasion and metastasis in squamous cell carcinoma of the esophagus. Human Pathology, 2006; 37: 569-77
20. Sauer T, Pedersen, Ebeltoft K, Næss O: Reduced expression of Claudin-7 in fine needle aspirates from breast carcinomas correlate with grading and metastatic disease. Cytopathology, 2005; 16: 193-98
21. Michl P, Barth C, Buchholz M et al: Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res, 2003;63: 6265-71
22. Rangel LBA, Agarwal R, D'Souza T et al: Tight junction proteins Claudin-3 and Claudin 4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin Cancer Res, 2003; 9: 2567-75
23. Soini Y: Expression of Claudins 1, 2, 3, 4, 5 and 7 in various types of tumours. Histopathology, 2005; 46: 551-60
24. Lee JW, Lee SJ, Seo J et al: Increased expressions of Claudin-1 and Claudin-7 during the progression of cervical neoplasia. Gynecol Oncol, 2005; 97: 53-59
25. Shibutani M, Noda E, Maeda K et al: Low expression of Claudin-1 and presence of poorly-differentiated tumor clusters correlate with poor prognosis in colorectal cancer. Anticancer Res, 2013; 33: 3301-6
26. Abdelzaher E, Rizk AM, Bessa SS, Omer KM: Predictive value of immunohistochemical expression of Claudin-1 in colonic carcinoma. J Egypt Natl Canc Inst, 2011; 23: 123-31
27. Yoshida T, Kinugasa T, Akagi Y et al: Decreased expression of Claudin-1 in rectal cancer: a factor for recurrence and poor prognosis. Anticancer Res, 2011; 31: 2517-25
28. Nakagawa S, Miyoshi N, Ishii H et al: Expression of CLDN1 in colorectal cancer: a novel marker for prognosis. Int J Oncol, 2011; 39: 791-96
29. Resnick MB, Konkin T, Routhier J et al: Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod Pathol, 2005; 18: 511-18
30. Ersoz S, Mungan S, Cobanoglu U et al: Prognostic importance of Claudin-1 and Claudin-4 expression in colon carcinomas. Pathol Res Pract, 2011; 15: 285-89
31. Huo Q, Kinugasa T, Wang L et al: Claudin-1 protein is a major factor involved in the tumorigenesis of colorectal cancer. Anticancer Res, 2009; 29: 851-57
32. Tang W, Dou T, Zhong M, Wu Z: Dysregulation of Claudin family genes in colorectal cancer in a Chinese population. Biofactors, 2011; 37: 65-73
33. Dhawan P, Singh AB, Deane NG et al: Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest, 2005; 115: 1765-76
34. Gröne J, Weber B, Staub E et al: Differential expression of genes encoding tight junction proteins in colorectal cancer: frequent dysregulation of Claudin-1, -8 and -12. Int J Colorectal Dis, 2007; 22: 651-59
35. Miwa N, Furuse M, Tsukita S et al: Involvement of Claudin-1 in the b-catenin/ Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol Res, 2001; 12: 469-76
36. Takehara M, Nishimura T, Mima S et al: Effect of Claudin expression on paracellular permeability, migration and invasion of colonic cancer cells. Biol Pharm Bull, 2009; 32: 825-31
37. Ueda J, Semba S, Chiba H: Heterogeneous expression of Claudin-4 in human colorectal cancer: decreased Claudin-4 expression at the invasive front correlates cancer invasion and metastasis. Pathobiology, 2007; 74: 32-41
38. Nakayama F, Semba S, Usami Y et al: Hypermethylation-modulated downregulation of Claudin-7 expression promotes the progression of colorectal carcinoma. Pathobiology, 2008;75: 177-85
39. Oshima T, Kunisaki C, Yoshihara K: Reduced expression of the Claudin-7 gene correlates with venous invasion and liver metastasis in colorectal cancer. Oncol Rep, 2008; 19: 953-59